Results 261 to 270 of about 467,415 (311)
Some of the next articles are maybe not open access.

Insulin Aspart-szjj: An Insulin Aspart Biosimilar

Clinical Drug Investigation
Insulin aspart-szjj (MERILOG™) is a biosimilar of the reference rapid-acting insulin analog, insulin aspart, and is approved for the same indication as reference insulin aspart: to improve glycemic control in adult and pediatric patients with diabetes mellitus. The physicochemical characteristics of insulin aspart-szjj were similar to reference insulin
openaire   +2 more sources

Engineering aspartate transcarbamylase

Biochimie, 1990
Aspartate transcarbamylase from Escherichia coli is one of the most extensively studied regulatory enzymes as a model of cooperativity and allostery. Numerous methods are used to engineer variants of this molecule: random and site-directed mutagenesis, dissociation and reassociation of the catalytic and regulatory subunits and chains, construction of ...
G, Hervé   +4 more
openaire   +2 more sources

Aspartate aminotransferase isoenzymes

Clinical Biochemistry, 1990
Aspartate aminotransferase (AST, EC 2.6.1.1) exists in human tissues as two distinct isoenzymes, one located in the cytoplasm (c-AST), and the other in mitochondria (m-AST). Striated muscle, myocardium, and liver tissues are the main sources of AST. A growing body of information suggests that determination of AST isoenzymes in human serum is useful in ...
openaire   +2 more sources

On aspartate transcarbamylase kinetics

Journal of Theoretical Biology, 1980
Abstract We present direct calculations on aspartate transcarbamylase (ATCase) kinetics. New knowledge about ATCase quaternary structure are considered. “Decorated” Ising model is used for evaluating the statistical properties. Comparison with experimental data is considered. The theoretical results agree very well with experimental data.
E, Marchi, J, Horas
openaire   +2 more sources

Inhibition of glutamate-aspartate transaminase by β-methylene-DL-aspartate

Biochemical Pharmacology, 1983
beta-Methylene-DL-aspartate, a new beta, gamma-unsaturated amino acid, is an irreversible inhibitor of soluble pig heart glutamate-aspartate transaminase (Ki approximately 3 mM with respect to the L-form; limiting rate constant for inactivation approximately 0.4 min-1).
A J, Cooper   +4 more
openaire   +2 more sources

Structure of the inhibitor of aspartate transcarbamylase, N-(phosphonacetyl)-L-aspartate

Journal of the American Chemical Society, 1984
Determination et comparaison des structures des deux composes N-(phosphonacetyl)-L-aspartate de tricyclohexylammonium et N-carbamoyl-L-aspartate de ...
ZANOTTI, GIUSEPPE   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy